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for a systematic review
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Abstract
Background: Several aetiological models of anorexia nervosa (AN) hold non-eating/weight-gain-related anxiety as a
factor relevant to the onset and maintenance of the disorder. Longitudinal studies that allow assessment of
this hypothesis have been conducted; however, the evidence has not yet been aggregated in a systematic
manner. The proposed study will systematically review articles describing prospective investigations of the
relationship between anxiety and AN development or maintenance, with the aim of providing a balanced
summary of current understanding and identifying areas for further research.
Methods/design: Electronic databases will be searched for articles investigating the longitudinal influence of
non-eating/weight-gain-related anxiety (anxiety disorders and trait anxiety) on the development/maintenance
of AN. References of eligible articles will be searched to ensure the identification of all relevant studies. Two
independent reviewers will complete the title and abstract, and full-text, screening, with a third independent
reviewer resolving any conflicts at each stage. A systematic review will be completed, and the quality of the
included studies, as well as the strength of the body of evidence generated, will be assessed and reported.
Discussion: Although there are limitations to the present review, understanding the current evidence for the
role of non-eating/weight-gain-related anxiety in AN can direct future research that may ensure accurate
aetiological models of AN and effective treatments.
Systematic review registration: The study is registered on PROSPERO under the reference number
CRD42017069644
Keywords: Aetiology, Anxiety, Anorexia nervosa: risk factor, Longitudinal studies
Background
Anorexia nervosa (AN) is characterised by the mainten-
ance of a significantly low body weight [1] that is
achieved by dietary restriction that persists despite se-
vere risks to physical health [2]. The factors promoting
the onset and continuation of excessive and pathological
starvation are poorly understood, preventing such fac-
tors being targeted by treatment interventions [3, 4]. As
a result, the recovery rate of AN is low, the relapse rate
is high, and the mortality rate is the greatest of any psy-
chiatric illness [5, 6].
The high levels of anxiety surrounding eating has
caused AN to be compared to anxiety disorders [3], and
anxious symptomatology in AN has been empirically in-
vestigated in attempts to better understand AN aeti-
ology. Supporting clinical observations of elevated
anxiety in individuals with AN, it is consistently reported
that individuals who experience AN are more likely to
have anxiety disorders and greater levels of anxious
symptomatology and trait anxiety, compared to the gen-
eral population [7–9]. This holds prior to the illness, at
the time of AN and in recovery [7]. Subsequently, a
number of models of illness have proposed anxiety as a
key factor in the development and maintenance of AN.
It is proposed that the high levels of anxiety individuals
with AN experience cause starvation to be particularly
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valuable, given dietary restriction affects neurobiological
systems that appear to modulate anxiety in AN [10–12].
The relief of anxiety caused by dietary restriction is
suggested to encourage excessive engagement in the
behaviour [10–12]. It is asserted that individuals with
AN come to depend on dietary restriction to avoid
extreme levels of anxiety, with this anxiety increas-
ingly focused on food and weight gain. Thus, when
anxiety is greater, it would be expected that restrict-
ive eating is more likely to occur in AN. Pre-meal
anxiety is related to reduced caloric intake at the
meal [13], and individuals with AN are more likely
to report restricting their intake at times that coin-
cide with high levels of state anxiety [14, 15]. This
suggests that traits and disorders that cause episodes
characterised by high state anxiety, such as anxiety
disorders and trait anxiety, would be negative prog-
nostic factors for AN, state anxiety serving to in-
crease engagement in dietary restriction.
An alternative hypothesis is that anxious traits and
anxiety disorders reflect underlying neurobiological ab-
normalities that predispose individuals to develop patho-
logical fear and avoidant responses [7, 16, 17]. The
abnormalities result in the development of fears and ab-
normal behaviour surrounding weight gain and eating
when weight concern is present and dieting is initiated.
In these models, it is only anxiety surrounding eating
and weight gain that is directly associated with contin-
ued dietary restriction. Non-eating/weight-gain concerns
are factors predictive of the onset and maintenance of
AN because they reflect the severity of eating/weight-re-
lated anxiety and of eating behaviours designed to man-
age this anxiety.
The relationship of trait anxiety and symptoms/diag-
noses of anxiety disorders (i.e. stable forms of anxiety
that do not specifically relate to eating/weight gain) with
both AN onset and maintenance has been probed in a
number of longitudinal studies. However, the evidence
gathered across these studies has not yet been synthe-
sised in a systematic manner. This prevents a fair evalu-
ation of the longitudinal relationship between anxiety
and AN, which is necessary for theoretical accounts of
AN, and disorder prevention/treatment interventions, to
be appropriately informed. It also means that the need
for further investigation in this area may not be fully ap-
preciated. This systematic review will gather and
organize evidence from a diverse range of observational
studies, to critically evaluate the nature of the relation-
ship between non-eating/weight gain-related anxiety,
which we refer to as anxiety in this manuscript, and AN.
The current protocol outlines the methods of our inves-
tigation, in accordance with the PRISMA-P checklist
(available in Additional file 1), which will address the fol-
lowing research questions:
1. Is anxiety related to the later onset of AN?
2. Is anxiety related to the maintenance of AN?
Methods
Eligibility criteria
Study designs
Retrospective and prospective cohort and case-control
studies that present original data and that investigated
the longitudinal relationship between anxiety and AN
development or maintenance will be eligible for inclu-
sion in the review. Studies must have measured anxiety
at one time point and have assessed AN symptoms at
least 1 year later to be included.
Participants
We will only include studies that include a human AN
population, and individuals in the AN sample recruited
must meet, or have previously met, full diagnostic cri-
teria for the disorder.
Exposures
Eligible exposures are symptoms/diagnosis of any anx-
iety disorder (excluding obsessive-compulsive disorder
or posttraumatic stress disorder) and trait anxiety, pro-
vided they have been assessed with a validated measure.
Studies that have assessed relationships between state
anxiety and AN pathology will not be included given we
are considering the relevance of more stable forms of
anxiety to AN. Further, we are specifically interested in
the relationship between non-eating/weight gain-related
anxiety and AN, and state anxiety assessments are likely
to capture anxiety related to eating and weight gain in
individuals with AN. While the range of eligible expo-
sures may seem broad, an initial scoping review of the
literature suggests this approach is reasonable and will
not result in an unmanageable amount of data to
synthesise.
Comparators
Studies may compare individuals with anxiety disorders,
or high levels of anxiety disorder symptoms/trait anxiety,
with individuals without these disorders/characteristics.
Outcomes
For studies investigating the relationship between anx-
iety and the development of AN, AN diagnosis is the
primary outcome. Secondary outcomes are severity of
behavioural/psychological symptoms of AN and body
mass index (BMI).
For studies investigating the relationship between anx-
iety and AN maintenance, the primary outcome is recov-
ery from AN. Secondary outcomes are severity of
behavioural/psychological symptoms of AN/changes in
these symptoms and BMI/change in BMI.
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Timing
Outcome data may be collected at different time points;
however, AN onset or maintenance must be assessed at
least 1 year after the time at which anxiety is measured
for the study to be included.
Setting
We impose no restrictions pertaining to study setting.
Language
Only studies reported in English will be included.
Information sources
Literature searches will be conducted on articles held in
Medline and PsychInfo using the OVID interface. To
identify relevant articles in these databases, a search
strategy has been produced and is available in
Additional file 2. Eligible studies will have been pub-
lished in a peer-reviewed journal and in the year 1980 or
subsequently. Reference lists of eligible studies identified
from database searches will be scanned to ensure we
capture all relevant research articles.
Data collection and analysis
Study selection
Following removal of duplicates, the titles and abstracts
of studies retrieved using the database searches will be
screened by two reviewers. The full text of potentially
eligible studies will be retrieved and assessed for inclu-
sion in the review by two reviewers. Should the full text
of a study not be accessible through institutional mem-
berships study authors will be contacted in order to re-
trieve the manuscript. The decision to include studies
will be based on criteria outlined in the preceding sec-
tion, and a third reviewer will resolve any discrepancies
between the screeners at both stages. Two reviewers
must also approve the inclusion of further studies identi-
fied from reference lists of the eligible articles found
using database searches. The reason for exclusion of any
study will be recorded, and the study selection process
presented in a PRISMA flow diagram.
Data extraction
Using a tailored data collection form, the following in-
formation will be extracted from each study:
1. Publication details: authors, title, publication date,
and country.
2. Study information: study setting and design, details
of exposure and outcome, details of comparator (if
appropriate), sample size at recruitment and
completion, follow-up period, and study measures.
3. Participant characteristics: demographics, illness
duration, BMI, number of hospitalisations, length of
illness, psychiatric co-morbidities, and use of
psychotropic medication.
4. Study results: findings in relation to the primary and
secondary outcomes will be reported, as will the
statistical methods employed in the investigation.
Where data are missing, we will attempt to contact
study authors to obtain this.
Risk of bias
The National Institute of Health’s Quality Assessment
Tool for Observational Cohort and Cross-Sectional
Studies [18] will be used to assess risk of bias for each
study. The checklist considers selection bias, blinding of
outcome assessors (researcher bias), withdrawal (attri-
tion bias), and selective reporting (reporting bias). Other
aspects of study quality are also considered: the validity
of exposure and outcome measures, risk of confounding,
sample size, and potential to capture dose-response rela-
tionships. Regarding the validity of exposure measures,
we are particularly concerned with evaluating the poten-
tial for these to capture anxiety that reflects the AN (i.e.
that related to eating and weight gain). For example, so-
cial phobia assessments may capture fears of eating in
public, which could be symptomatic of the AN rather
than of social phobia. This would give rise to false infer-
ences concerning the relationship between non-eating/
weight gain-related anxiety and AN.
Risk of bias and quality for all studies will be assessed
by two reviewers, with discrepancies resolved by a third
reviewer, to ensure reliability of the review. If eligible
review studies are identified, the outcomes of these
review studies will be compared to the outcomes re-
ported by articles included in the present review, to
detect systematic reporting biases. The strength of the
body of evidence collected in the course of the review
will be assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) sys-
tem [19].
Data synthesis
Studies will be categorised according to whether they as-
sess the relationship of anxiety with the development or
the maintenance of AN. Within these two categories,
studies will be grouped further, according to the type of
anxiety considered for its influence on AN (i.e. specific
anxiety disorders and trait anxiety). Ideally, meta-
analyses would be conducted to determine the pooled
effect size pertaining to the longitudinal relationship of
each type of anxiety with both AN onset and AN main-
tenance. However, preliminary investigations suggest
that the number of eligible studies within each category,
and the heterogeneity of these studies, will mean meta-
analyses are not feasible.
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A systematic narrative review will describe findings of
the included studies, and the similarities and differences
between studies, for studies grouped by outcome (AN
onset or maintenance) and type of anxiety measured. A
table outlining findings of each study will also be pro-
vided. RevMan version 5.3 [20] will be used to handle
and synthesise the data of the included studies, for com-
pletion of the qualitative review.
Discussion
With the inclusion of anxiety in aetiological models of
AN, it is important that the relevance of anxiety to AN
development and maintenance is clarified. This study
will provide the first, much needed, systematic synthesis
of longitudinal studies that investigate the relationship
between anxiety and AN. By considering a range of anx-
iety exposures (i.e. anxiety disorder diagnoses/symptoms
and trait anxiety), we hope to be able to evaluate a suffi-
cient number of studies for our research questions to be
addressed.
The planned quality assessment is extensive, to enable
a comprehensive evaluation of the risk of bias within
and across included studies, promoting the validity of
conclusions arising from the review. The extent of the
data extracted from studies will allow for the identifica-
tion of differences in findings that may arise from par-
ticipant and study characteristics. Most importantly, our
method is transparent and explicitly outlined in detail,
allowing its replication, as well as assessment of its qual-
ity, by others.
Anticipated challenges lie in collecting a sufficient
number of studies for firm conclusions regarding the re-
lationship between particular types of anxiety and AN
onset/maintenance to be made. Interpreting the body of
evidence surrounding AN maintenance may also be
problematic given the definitions of recovery are not
standardised in the field of eating disorders [21]. We
consider the outcome of AN recovery, as opposed to re-
mission or relapse, in an attempt to focus the research
question. However, understanding the relationship of
anxiety with both remission and relapse in AN would
further inform knowledge of the factors associated with
AN maintenance.
Because of their longitudinal nature, studies of the re-
view are likely to be subject to high levels of attrition,
which is an issue that has implications on the validity of
conclusions that may be drawn from the review. A fur-
ther limitation is that we will be unable to parse apart
the explanatory power of different types of anxiety on
AN development/maintenance given studies may have
measured only one type of anxiety, focusing on one dis-
order or trait anxiety for example. Alternatively, studies
may not have considered the unique contribution of
each type of measured anxiety to AN risk. The review
will not be able to determine whether non-eating/weight
gain-related anxiety directly causes dietary restriction, or
if such reflects an underlying process that promotes con-
cern surrounding eating and weight gain. However, find-
ings can inform the value of continuing to study anxiety
that does not surround eating and weight gain in rela-
tion to AN.
Despite the discussed limitations, it is important for
evidence surrounding the longitudinal influence of anx-
iety on AN to be synthesised so that progress with inves-
tigation and understanding may be presented. By
highlighting areas that require further study, the review
may encourage the development of accurate aetiological
models of AN, which may inform effective treatment.
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